Follow
Rebecca Meyer-Schuman
Rebecca Meyer-Schuman
Unknown affiliation
Verified email at bcm.edu
Title
Cited by
Cited by
Year
Emerging mechanisms of aminoacyl-tRNA synthetase mutations in recessive and dominant human disease
R Meyer-Schuman, A Antonellis
Human molecular genetics 26 (R2), R114-R127, 2017
1552017
Allele-specific RNA interference prevents neuropathy in Charcot-Marie-Tooth disease type 2D mouse models
KH Morelli, LB Griffin, NK Pyne, LM Wallace, AM Fowler, SN Oprescu, ...
The Journal of clinical investigation 129 (12), 5568-5583, 2019
552019
Substrate interaction defects in histidyl‐tRNA synthetase linked to dominant axonal peripheral neuropathy
JA Abbott, R Meyer‐Schuman, V Lupo, S Feely, I Mademan, SN Oprescu, ...
Human mutation 39 (3), 415-432, 2018
372018
Cysteinyl-tRNA synthetase mutations cause a multi-system, recessive disease that includes microcephaly, developmental delay, and brittle hair and nails
ME Kuo, AF Theil, A Kievit, MC Malicdan, WJ Introne, T Christian, ...
The American Journal of Human Genetics 104 (3), 520-529, 2019
362019
MARS variant associated with both recessive interstitial lung and liver disease and dominant Charcot-Marie-Tooth disease
J Rips, R Meyer-Schuman, O Breuer, R Tsabari, A Shaag, S Revel-Vilk, ...
European journal of medical genetics 61 (10), 616-620, 2018
222018
Bi‐allelic mutations in HARS1 severely impair histidyl‐tRNA synthetase expression and enzymatic activity causing a novel multisystem ataxic syndrome
D Galatolo, ME Kuo, P Mullen, R Meyer‐Schuman, S Doccini, R Battini, ...
Human mutation 41 (7), 1232-1237, 2020
162020
A recurrent GARS mutation causes distal hereditary motor neuropathy
DC Lee, R Meyer‐Schuman, C Bacon, ME Shy, A Antonellis, SS Scherer
Journal of the peripheral nervous system 24 (4), 320-323, 2019
142019
A novel mutation in MARS in a patient with Charcot-Marie-Tooth disease, axonal, type 2U with congenital onset
MK Gillespie, HJ McMillan, KD Kernohan, IA Pena, R Meyer-Schuman, ...
Journal of neuromuscular diseases 6 (3), 333-339, 2019
142019
Evidence for a dominant‐negative mechanism in HARS1‐mediated peripheral neuropathy
R Meyer‐Schuman, A Antonellis
The FEBS journal 288 (1), 91-94, 2021
72021
Dominant NARS1 mutations causing axonal Charcot–Marie–Tooth disease expand NARS1-associated diseases
D Beijer, S Marte, JC Li, W De Ridder, JZ Chen, ALD Tadenev, KE Miers, ...
Brain communications 6 (2), fcae070, 2024
22024
A humanized yeast model reveals dominant-negative properties of neuropathy-associated alanyl-tRNA synthetase mutations
R Meyer-Schuman, S Marte, TJ Smith, SME Feely, M Kennerson, ...
Human molecular genetics 32 (13), 2177-2191, 2023
12023
Predictive modeling provides insight into the clinical heterogeneity associated with TARS1 loss-of-function mutations
R Meyer-Schuman, AR Cale, JA Pierluissi, KE Jonatzke, YN Park, ...
bioRxiv, 2024.03. 25.586600, 2024
2024
BRAIN COMMUNICATIONS
D Beijer, S Marte, JC Li, W De Ridder, JZ Chen, ALD Tadenev, KE Miers, ...
2024
Appendix D: A Humanized Yeast Model Reveals Dominant-Negative Properties of Neuropathy-Associated Alanyl-tRNA Synthetase Mutations
R Meyer-Schuman, S Marte, T Smith, S Feely, M Kennerson, G Nicholson, ...
Modification and Sequence of tRNAs and mRNAs Impact Translational Speed and …, 2022
2022
NARS as a candidate gene in dominant inherited peripheral neuropathies
D Beijer, W De Ridder, T Deconinck, R MacDonell, W Marques Jr, ...
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM 25 (4), 482-483, 2020
2020
Allele-specific RNA interference: Precision gene therapy for dominant inherited neuropathy
R Burgess, K Morelli, L Griffin, N Pyne, L Wallace, A Fowler, S Oprescu, ...
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM 23 (4), 314-315, 2018
2018
Cover Image, Volume 39, Issue 3
JA Abbott, R Meyer‐Schuman, V Lupo, S Feely, I Mademan, SN Oprescu, ...
Human mutation 39 (3), i-i, 2018
2018
The system can't perform the operation now. Try again later.
Articles 1–17